Personalis and Tempus AI are adding colorectal cancer as a new indication to their existing commercialization agreement.

Covid-19 exposed wide inequities in health in the United States and around the world. But health disparities persisted long before the pandemic. In this article the authors explain why businesses ...

Tempus AI TEM is entering a phase of strong operating momentum, backed by significant acceleration in both revenues and gross profit. This trend became particularly clear in the company’s last two ...

TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Timbercreek Financial (TSX: TF) (the “Company”) is pleased to announce that it has declared a monthly cash dividend of $0.0575 per common share (“Common ...

Learn how AARP can help take care of your brain — from the 'Taking Care' documentary to Staying Sharp with healthy habits to reduce your dementia risk.

SAN DIEGO, June 23, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers of Tempus AI, Inc. (NASDAQ: TEM) common stock between August 6, 2024 and May ...

The legislation would represent a massive contraction to health care coverage on Long Island and in the nation.

Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 30, 2025 /PRNewswire/ -- Several experts are seeing that value of AI's total overhaul ...